Altimmune
ALT
ALT
174 hedge funds and large institutions have $282M invested in Altimmune in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
22.94% less ownership
Funds ownership: 82.78% → 59.84% (-23%)
38% less capital invested
Capital invested by funds: $453M → $282M (-$171M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
174
Holding in Top 10
1
Calls
$12.4M
Puts
$8.07M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$11.2M | |
| 3 | +$9.55M | |
| 4 |
BlackRock
New York
|
+$9.44M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
+$6.54M |
Top Sellers
| 1 | -$35M | |
| 2 | -$11.6M | |
| 3 | -$10.1M | |
| 4 |
Morgan Stanley
New York
|
-$6.8M |
| 5 |
Citigroup
New York
|
-$5.21M |